Education
About Us
Working with TipRanks
Follow Us
Mustang Bio Inc (MBIO)
NASDAQ:MBIO
MBIO Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.95 - $31.00
Previous CloseN/A
Volume2.68M
Average Volume (3M)102.57K
Market Cap
$4.47M
Enterprise Value$2.00B
Total Cash (Recent Filing)$14.23M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta1.09
Next Earnings
May 09, 2025EPS Estimate
-5.5Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-43.66
Shares Outstanding3,532,452
10 Day Avg. Volume125,917
30 Day Avg. Volume102,566
Financial Highlights & Ratios
PEG Ratio-5.66
Price to Book (P/B)44.14
Price to Sales (P/S)0.00
P/FCF Ratio-29.97
Enterprise Value/Market Cap447.45
Enterprise Value/Revenue346.64
Enterprise Value/Gross Profit-6.66K
Enterprise Value/Ebitda-25.69
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Mustang Bio News
PremiumCompany Announcements
Mustang Bio Reports Improved Financials Amid Strategic Adjustments
PremiumCompany Announcements
Mustang Bio Sells Assets to AbbVie, Transfers Lease
Options Prices
Currently, No data available
---
Ownership Overview
5.68% Insiders
0.57% Mutual Funds
1.29% Other Institutional Investors
92.42% Public Companies and Individual Investors
MBIO FAQ
What was Mustang Bio Inc’s price range in the past 12 months?
Mustang Bio Inc lowest stock price was $0.95 and its highest was $31.00 in the past 12 months.
What is Mustang Bio Inc’s market cap?
Mustang Bio Inc’s market cap is $4.47M.
When is Mustang Bio Inc’s upcoming earnings report date?
Mustang Bio Inc’s upcoming earnings report date is May 09, 2025 which is 55 days ago.
How were Mustang Bio Inc’s earnings last quarter?
Mustang Bio Inc released its earnings results on Mar 24, 2025. The company reported -$0.95 earnings per share for the quarter, beating the consensus estimate of -$5.5 by $4.55.
Is Mustang Bio Inc overvalued?
According to Wall Street analysts Mustang Bio Inc’s price is currently Overvalued.
Does Mustang Bio Inc pay dividends?
Mustang Bio Inc does not currently pay dividends.
What is Mustang Bio Inc’s EPS estimate?
Mustang Bio Inc’s EPS estimate is -5.5.
How many shares outstanding does Mustang Bio Inc have?
Mustang Bio Inc has 3,532,452 shares outstanding.
What happened to Mustang Bio Inc’s price movement after its last earnings report?
Mustang Bio Inc reported an EPS of -$0.95 in its last earnings report, beating expectations of -$5.5. Following the earnings report the stock price went down -1.695%.
Which hedge fund is a major shareholder of Mustang Bio Inc?
Currently, no hedge funds are holding shares in MBIO
Company Description
Mustang Bio Inc
Mustang Bio, Inc. (MBIO) is a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for the treatment of cancer and rare genetic diseases. The company's primary focus lies in advancing its gene and cell therapy platforms, which are designed to harness the power of the patient's immune system to target and eliminate diseased cells. Mustang Bio is involved in both clinical and preclinical development stages, working on a pipeline of promising therapeutic candidates.